There are 700 resources available
220P - Treatment outcomes of amrubicin monotherapy for patients with advanced hepatobiliary and pancreatic neuroendocrine carcinoma
Presenter: Kanae Inoue
Session: Poster Display session
221P - TEMCAP regimen as first-line therapy in patients with advanced gastroenteropancreatic neuroendocrine tumors (GEP-NETs) at a Latin American reference center: A ten-year follow-up study
Presenter: wagner cruz diaz
Session: Poster Display session
222P - Treatment modalities in pancreatic neuroendocrine tumors: A survival analysis from SEER database
Presenter: lana amouri
Session: Poster Display session
223P - Navigating neuroendocrine tumors: Insights from oncologists in Mexico
Presenter: Julieta Gómez
Session: Poster Display session
224P - Genomic patterns and clinical implications in gastroenteropancreatic neuroendocrine neoplasms
Presenter: Gordon Moffat
Session: Poster Display session
225P - Nuclear exporter protein exportin 1 (XPO1) as a novel therapeutic target in pancreatic neuroendocrine tumors
Presenter: Asfar Azmi
Session: Poster Display session
226P - Risk of relapse following surgical resection of localized appendiceal adenocarcinoma
Presenter: John Paul Shen
Session: Poster Display session
227P - Clinical outcomes and molecular characterization of appendiceal goblet cell adenocarcinoma in 414 patients
Presenter: Abdelrahman Yousef
Session: Poster Display session
228P - BRAF mutation in appendiceal adenocarcinoma: Key contrasts with colorectal cancer and implications for treatment
Presenter: John Paul Shen
Session: Poster Display session
229P - BISQUIT: A randomized phase II trial of Prebiotics and Probiotics (PreProbiotics) during chemoradiation (CRT) for patients (pts) with squamous cell carcinoma of the anal canal (SCCA)
Presenter: Rachel Riechelmann
Session: Poster Display session